Skip to main content

Aceragen, Inc.

ACGNDelisted Aug 16, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000861838

Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Aceragen, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of ACGN: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders3431−3
Shares4.25M3.73M−521.8K (−12.3%)
Value$2.42M$1.86M−$559.0K (−23.1%)

New holders (3)

Institutions that held Aceragen, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to ACGN in Q1 2022
InstitutionSharesValue% of portfolio
Assenagon Asset Management S.A.54,773$27.0K0.00%
Virtu Financial LLC46,368$23.0K0.00%
Johnson Investment Counsel Inc42,128$21.0K0.00%

Sold out (6)

Institutions that held Aceragen, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of ACGN in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Millennium Management LLC48,568$28.0K
Jane Street Group, LLC48,399$28.0K
Two Sigma Advisers, LP46,347$26.0K
Two Sigma Securities, LLC17,781$10.0K
Engineers Gate Manager LP15,333$9.00K
Cutler Group LP1,300$0